Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Poor

Showing results (501-510 of 518) with videos related to

Pageof 52
Sort By:
Genes|January 13, 2021
Meta-Analysis of Mutations in <i>ALOX12B</i> or <i>ALOXE3</i> Identified in a Large Cohort of 224 PatientsAlrun Hotz, Julia Kopp, Emmanuelle Bourrat, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 30, 2015
Vertebral Scheuermann's disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and overG Armbrecht, D Felsenberg, M Ganswindt, et al.
Bone|March 22, 2005
Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis StudyS Kaptoge, L I Benevolenskaya, A K Bhalla, et al.
Archives of Academic Emergency Medicine|September 19, 2024
Monkeypox: A Comprehensive Review of Virology, Epidemiology, Transmission, Diagnosis, Prevention, Treatment, and Artificial Intelligence ApplicationsErfan Rahmani, Ziba Bayat, Mehrdad Farrokhi, et al.
Journal of Medicinal Chemistry|February 6, 2018
The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular DegenerationChristopher M Adams, Karen Anderson, Gerald Artman, et al.
Nature Communications|March 24, 2017
Long-acting protein drugs for the treatment of ocular diseasesJoy G Ghosh, Andrew A Nguyen, Chad E Bigelow, et al.
Nature|May 20, 2026
Mitochondrial L-2-hydroxyglutarate is a physiological signalling metaboliteRam P Chakrabarty, Jonathan G Van Vranken, Yuki Aoi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 13, 2003
Determinants of the size of incident vertebral deformities in European men and women in the sixth to ninth decades of age: the European Prospective Osteoporosis Study (EPOS)J Reeve, M Lunt, D Felsenberg, et al.
Science Advances|July 3, 2026
A meta-analysis of carbon losses and gains from tropical moist forest degradation and regenerationViola Heinrich, Amelia Holcomb, Simon Besnard, et al.
JAMA Dermatology|August 31, 2022
Assessment of the Genetic Spectrum of Uncombable Hair Syndrome in a Cohort of 107 IndividualsF Buket Basmanav, Nicole Cesarato, Sheetal Kumar, et al.
Pageof 52

Showing results (501-510 of 518) with videos related to

Sort By:
Pageof 52
Genes|January 13, 2021
Meta-Analysis of Mutations in <i>ALOX12B</i> or <i>ALOXE3</i> Identified in a Large Cohort of 224 PatientsAlrun Hotz, Julia Kopp, Emmanuelle Bourrat, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 30, 2015
Vertebral Scheuermann's disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and overG Armbrecht, D Felsenberg, M Ganswindt, et al.
Bone|March 22, 2005
Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis StudyS Kaptoge, L I Benevolenskaya, A K Bhalla, et al.
Archives of Academic Emergency Medicine|September 19, 2024
Monkeypox: A Comprehensive Review of Virology, Epidemiology, Transmission, Diagnosis, Prevention, Treatment, and Artificial Intelligence ApplicationsErfan Rahmani, Ziba Bayat, Mehrdad Farrokhi, et al.
Journal of Medicinal Chemistry|February 6, 2018
The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular DegenerationChristopher M Adams, Karen Anderson, Gerald Artman, et al.
Nature Communications|March 24, 2017
Long-acting protein drugs for the treatment of ocular diseasesJoy G Ghosh, Andrew A Nguyen, Chad E Bigelow, et al.
Nature|May 20, 2026
Mitochondrial L-2-hydroxyglutarate is a physiological signalling metaboliteRam P Chakrabarty, Jonathan G Van Vranken, Yuki Aoi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 13, 2003
Determinants of the size of incident vertebral deformities in European men and women in the sixth to ninth decades of age: the European Prospective Osteoporosis Study (EPOS)J Reeve, M Lunt, D Felsenberg, et al.
Science Advances|July 3, 2026
A meta-analysis of carbon losses and gains from tropical moist forest degradation and regenerationViola Heinrich, Amelia Holcomb, Simon Besnard, et al.
JAMA Dermatology|August 31, 2022
Assessment of the Genetic Spectrum of Uncombable Hair Syndrome in a Cohort of 107 IndividualsF Buket Basmanav, Nicole Cesarato, Sheetal Kumar, et al.
Pageof 52